Atrion (ATRI) Return on Equity ROE from the second quarter 2024 to second quarter 2023 and annually, average high and low, overall ranking from Jun 30 2024 to Jun 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Atrion Corporation  (NASDAQ: ATRI)

Atrion's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Atrion in the second quarter 2024?
Atrion Corporation achieved a return on average equity (ROE) of 5.21 % in its second quarter 2024, which is below Atrion's average return on equity, which stands at 16.85%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 49 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2024 from 1422 to 1922.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Equity Change -0.85 % 1.38 % 1.4 % -2.47 % -
Y / Y Net Income Change -93.87 % -19.89 % -22.81 % -66.75 % -29.79 %
Net Income (TTM) in Millions 13 19 19 21 27
Return On Equity (TTM) 5.21 % 7.75 % 8.07 % 8.89 % 11.27 %
ATRI's Total Ranking # 1922 # 1422 # 1492 # 1313 #
Equity (TTM) in Millions 239 242 243 240 241
Seq. Equity Change -1.26 % -0.4 % 1.13 % -0.3 % 0.95 %
Seq. Net Income Change -85.6 % -56.54 % 118.58 % -55.22 % 88.32 %

Back to ATRI Management Effectiveness >> ATRI's 5 Years Annual ROE >> Compare ATRI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 50
Sector # 153
Overall # 1922

Return On Equity Statistics
High Average Low
20.83 %
16.85 %
5.21 %
(Dec 31 2017)   (Jun 30 2024)





ATRI Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 243 240 0 238 211
Y / Y Equity Change 1.4 % 99542.68 % -99.9 % 12.86 % 14.31 %
Net Income in Millions 19 35 32 37 34
Y / Y Net Income Change -44.55 % 9.01 % -12.64 % 7.32 % -6.39 %
Return On Equity 7.99 % 14.61 % 13358.99 % 15.45 % 16.25 %

Back to ATRI Management Effectiveness >> ATRI's 5 Years Annual ROE >> Compare ATRI ROE to its Competitors




Annual Roe Comment
In 2023 ROE decreased compared to the previous year to 7.99 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ATRI's' Return on Equity at Yahoo Finance
ATRI's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ATRI's Competitors
Subscribers only: Roe for Atrion's Suppliers
Subscribers only: Return On Equity for ATRI's Customers




Companies with similar Return On Equity at Jun 30 2024, within Healthcare Sector ROE
Abbott Laboratories  14.33 %
Catalyst Pharmaceuticals Inc   14.30 %
Reflect Scientific Inc  14.15 %
Zynex inc   14.15 %
Quest Diagnostics Inc  13.73 %
Sensus Healthcare Inc   13.46 %
Krystal Biotech Inc   13.36 %
The Pennant Group Inc   12.95 %
Haemonetics Corporation  12.85 %
Electromed Inc   12.64 %
Charles River Laboratories International inc   12.48 %
Utah Medical Products Inc  12.41 %
Lemaitre Vascular Inc   12.41 %
Third Harmonic Bio Inc   12.33 %
Progyny Inc   11.97 %
Align Technology inc   11.96 %
Conmed Corporation  11.71 %
Jazz Pharmaceuticals Plc  10.76 %
Relmada Therapeutics Inc  10.56 %
Nature s Sunshine Products inc   10.49 %
Royalty Pharma Plc  10.49 %
Lifevantage Corp  10.07 %
National Healthcare Corp  9.96 %
Docgo Inc   9.88 %
Sotera Health Company  9.59 %
Merit Medical Systems Inc  9.48 %
Boston Scientific Corporation  9.18 %
Addus Homecare Corp  9.07 %
Fonar Corporation  9.03 %
Vaso Corporation  8.63 %

Date modified: 2024-09-15T09:08:20+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.